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The mammalian CNS contains a ubiquitous popula-
tion of glial progenitors known as NG2+ cells that
have the ability to develop into oligodendrocytes and
undergo dramatic changes in response to injury and
demyelination. Although it has been reported that
NG2+ cells are multipotent, their fate in health and
disease remains controversial. Here, we generated
PDGFaR-CreER transgenic mice and followed their
fate in vivo in the developing and adult CNS. These
studies revealed that NG2+ cells in the postnatal
CNS generate myelinating oligodendrocytes, but not
astrocytes or neurons. In regions of neurodegenera-
tion in the spinal cord of ALS mice, NG2+ cells
exhibited enhanced proliferation and accelerated
differentiation into oligodendrocytes but remained
committed to the oligodendrocyte lineage. These
results indicate that NG2+ cells in the normal CNS
areoligodendrocyteprecursorswith restricted lineage
potential and that cell loss andgliosis are not sufficient
to alter the lineage potential of these progenitors.
INTRODUCTION
The central nervous system (CNS) of mammals has a limited
capacity to replace cells that have been lost as a consequence
of age-related degeneration, injury, or neurological disease.
Nevertheless, there are distinct groups of neural stem cells
(NSCs) that retain the ability to generate neurons throughout
life, indicating that significant cell replacement is possible
(Zhao et al., 2008). In addition to NSCs confined to the subven-
tricular zone of the lateral ventricle and subgranular zone of the
dentate gyrus, the adult brain and spinal cord contain a widely
distributed, abundant class of progenitors known as NG2+ cells
(also termed oligodendrocyte precursor cells [OPCs]) because
they express the chondroitin sulfate proteoglycan NG2 (Nish-
iyama et al., 2009); nearly all (99%) of these glial cells also
express the alpha receptor for platelet-derived growth factor668 Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc.(PDGFaR) (Nishiyama et al., 1996; Rivers et al., 2008). NG2+
cells are mitotically active and exhibit enhanced proliferation in
response to acute CNS injury, ischemia, and demyelination (Lev-
ine et al., 2001). Thus, an accurate delineation of the fate of these
ubiquitous NG2+ cells is critical for determining whether they
participate in cell replacement during normal CNS aging and
initiate repair following injury or disease.
Although NG2+ cells were originally thought to serve only as
oligodendrocyte (OL) precursors, recent studies suggest that
these progenitors may have greater lineage potential (Guo
et al., 2009; Rivers et al., 2008; Zhu et al., 2008a, 2008b). NG2+
cells can differentiate into OLs, astrocytes, or neurons in vitro,
depending on the growth conditions (Kondo and Raff, 2000),
and studies in which NG2+ cells have been labeled in vivo using
transgenic approaches suggest that they also have the capacity
to develop into interneurons in the hippocampus and olfactory
bulb (Aguirre and Gallo, 2004; Aguirre et al., 2004; Belachew
et al., 2003), principal neurons in the piriform cortex (Guo et al.,
2009; Rivers et al., 2008), and astrocytes in ventral areas of the
brain and spinal cord (Guo et al., 2009; Zhu et al., 2008a,
2008b). These findings support the hypothesis that NG2+ cells
represent a widely distributed population of multipotent progen-
itors that can regenerate major classes of neurons and glia.
However, this conclusion remains contentious because NG2+
cells have not been observed to consistently generate these
different cell types in vivo. The apparently divergent behavior
of these progenitors could reflect limitations of the approaches
used to define their fate or that NG2+ cells are intrinsically hetero-
geneous and were incompletely sampled.
In the context of acute brain injury (Hampton et al., 2004),
demyelination (Keirstead et al., 1998), and neurodegenerative
disease, such as amyotrophic lateral sclerosis (ALS) (Magnus
et al., 2008), NG2+ cells have been shown to upregulate NG2
and dramatically increase their proliferation rate. The changes
in local environment that accompany these injuries may enable
NG2+ cells to exhibit greater lineage plasticity and participate
in cell replacement (Magnus et al., 2008; Sellers et al., 2009),
although the fate of proliferating NG2+ cells and the conse-
quences of their change in behavior in neurodegenerative
disease have not been determined.
Here, we examined the fate of NG2+ cells in the normal CNS
through genetic lineage tracing in vivo using a line of mice that
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Fate of NG2+ Cells in Health and Diseaseexpress tamoxifen-inducible Cre under control of the PDGFaR
promoter and, to our knowledge, report the first analysis of
NG2+ cell fate in a primary neurodegenerative disease. We
show that resident NG2+ cells develop into myelinating OLs in
brain and spinal cord during early postnatal and adult life;
however, in contrast to previous results, these cells did not
generate neurons or astrocytes in any region of the brain or
spinal cord. Although NG2+ cells in mature gray matter divided
and differentiated less frequently than in white matter, clonal
analysis indicated that individual NG2+ cells in both regions
retain the capacity to proliferate and generate OLs, suggesting
that NG2+ cells are not intrinsically heterogeneous with regard
to their ability to divide and differentiate, as previously suggested
(Bouslama-Oueghlani et al., 2005; Dimou et al., 2008; Rivers
et al., 2008). Moreover, fate mapping of NG2+ cells in the spinal
cord of a mouse model of ALS revealed that enhanced prolifer-
ation of these progenitors was accompanied by facilitated differ-
entiation but that NG2+ cells remained constrained to the OL
lineage. These results suggest that NG2+ cells are not multipo-
tent progenitors but rather OL precursors with restricted lineage
potential, which contribute to homeostatic regulation of OLs in
the normal and diseased CNS.
RESULTS
Efficient In Vivo Induction of Cre Activity in NG2+ Cells
NG2+ cells in the CNS express both NG2 and PDGFaR (Nish-
iyama et al., 1996; Rivers et al., 2008), and both genes are rapidly
downregulated upon differentiation. Although NG2 immunolab-
eling is most often used to identify this class of glial cells, and
the NG2 promoter has been used to control transgene expres-
sion in NG2+ cells in vivo (Ziskin et al., 2007), this proteoglycan
is also expressed by perivascular pericytes (Stallcup, 2002),
and by some macrophage/microglial cells after CNS injury (Bu
et al., 2001). In contrast, PDGFaR is not expressed by activated
microglia (Bu et al., 2001), suggesting that the PDGFaRpromoter
may be more appropriate for restricting transgene expression to
NG2+ cells in both normal and disease contexts. To determine
the fate of NG2+ cells in vivo, we used the bacterial artificial
chromosome (BAC) modification method (Yang et al., 1997) to
generate transgenic mice in which an inducible form of Cre
recombinase (CreER) is expressed under control of mouse
PDGFaR promoter (see Figure S1A available online). After
crossing to Z/EG reporter mice, three PDGFaR-CreER;Z/EG
lines exhibited widespread EGFP expression in small, stellate-
shaped NG2+PDGFaR+ cells in the brain and spinal cord
4 days after administration of 4-hydroxytamoxifen (4HT) at post-
natal day 30 (P30+4). The line that exhibited the largest number
of EGFP+ cells in response to 4HT was selected for further study
(Figures S1B–S1H). EGFP+ cells were not observed when these
PDGFaR-CreER;Z/EG mice were injected with vehicle alone,
indicating that Cre activity is tightly controlled by 4HT (Figures
S1B and S1C).
When PDGFaR-CreER;Z/EG mice were examined at P30+4,
most EGFP+ cells in the forebrain (corpus callosum, cortex,
hippocampus) and spinal cord (both gray and white matter)
were PDGFaR+. Of the remaining EGFP+PDGFaR cells, most
were immunopositive for Sox10, an OL lineage-specific tran-scription factor in the CNS (Figures S1D and S1H), indicating
that they likely represent pre-myelinating or immature OLs that
developed from NG2+ cells in the period after 4HT administra-
tion. EGFP+ cells did not exhibit immunoreactivity to GFAP or
NeuN in these regions (Figures S1E– S1H), indicating that Cre
was not induced within astrocytes or neurons. In addition to
NG2+ glial cells, EGFP also was expressed by choroid plexus
ependymal cells and a subset of PDGFbR+ perivascular cells
(pericytes) (Figure S2), in accordance with the pattern of PDGFaR
mRNA or protein expression (Pringle et al., 1992; Su et al., 2008).
PDGFaR-CreER mice also were crossed with ROSA26-EYFP
and ROSA26-mGFP (mT/mG) (Muzumdar et al., 2007) Cre
reporter mice, which exhibited higher recombination efficiency;
in these double transgenic mice, 83%–94% of NG2+ cells in
major gray matter regions became reporter positive within
a few days after 4HT administration at P30 (Figure S3 and Table
S1). Thus, PDGFaR-CreER mice provide an effective means to
determine the fate of NG2+ cells in vivo under both normal and
pathological conditions.
OLs Are Generated Rapidly from NG2+ Cells in the Early
Postnatal Brain
Themajority of myelinating OLs appear in the mouse brain within
4 weeks after birth (Miller, 2002). Although NG2+ cells are re-
garded as OL progenitors during early postnatal life, previous
studies have not directly followed the fate of NG2+ cells in vivo
during this period, due to nonspecific Cre expression or lack of
temporal control of Cre activity in available mice lines (Dimou
et al., 2008; Rivers et al., 2008; Zhu et al., 2008a). To determine
the identity of the progenitors responsible for OL generation as
well as the rate of OL development during this period, we admin-
istered 4HT to PDGFaR-CreER;Z/EG at P4 and followed the
appearance of EGFP+ cells in the corpus callosum and dorsal
cortex over the next 4 weeks. Two days after 4HT (P4+2),
EGFP+ PDGFaR+ cells were visible throughout the brain that
had stellate morphologies typical of NG2+ cells (Figures 1A
and 1B). Over the next several weeks, the number of EGFP+ cells
gradually increased, and many EGFP+ cells exhibited more
extensive processes, particularly in the corpus callosum (Figures
1C–1H). Five days after 4HT injection (P4+5), more than 35% of
EGFP+ cells in the corpus callosum were PDGFaR, although
they were Olig2+ and Sox10+ (Figures 1D and 1F), indicating
that they remained in the OL lineage. By P4+11, the majority of
callosal EGFP+ cells were PDGFaR and often exhibited
numerous parallel-oriented processes characteristic of OLs
(Figures 1F and1I), and by P4+28 most EGFP+ cells exhibited
immunoreactivity to APC (CC1), a marker of mature OLs (Figures
1H and 1J). These results indicate that the vast majority of NG2+
cells residing in the corpus callosum during the first postnatal
week rapidly differentiate into OLs within 4 weeks (Figure 1J).
Within the gray matter regions of the dorsal cortex (cingulate
and motor cortex) and striatum, most NG2+ cells also developed
into OLs within 4 weeks, as determined by the loss of PDGFaR
expression (Figures 1I and 1J) and co-localization between
EGFP and CC1 or MBP at P4+28 (Figures 1J–1L). Although the
rate of OL development was slower in cortex than in corpus cal-
losum, more than 70% of cortical EGFP+ cells were PDGFaR
after 2 weeks (Figure 1I), indicating that these cells hadNeuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc. 669
Figure 1. OLs Develop Rapidly from NG2+
Cells during Early Postnatal Life
(A, C, E, and G) Images of EGFP+ cells in coronal
brain sections of PDGFaR-CreER;Z/EG mice
taken 2 (A), 5 (C), 11 (E), or 28 days (G) after 4HT
administration at P4. Nuclei are stained by DAPI.
(B, D, F, and H) Confocal images showing EGFP+
cells that were immunoreactive to PDGFaR,
Olig2, Sox10, or CC1 in the corpus callosum.
Yellow arrows indicate PDGFaR+ cells, and white
arrowheads indicate PDGFaROlig2+ (D),
PDGFaRSox10+ (F), or PDGFaRCC1+ cells (H).
Scale bars represent 500 mm (A, C, E, and G) or
20 mm (B, D, F, and H). (I) Changes in the
percentage of PDGFaREGFP+ cells in the corpus
callosum (CC, filled circles) and cortex (CTX, open
circles) over time after 4HT administration at P4.
(J) Histogram showing the number of EGFP+ NG2+
cells (PDGFaR+), pre-myelinating OLs (PDGFa
RCC1), and OLs (CC1+) in the cortex (CTX)
and corpus callosum (CC) of PDGFaR-CreER;Z/
EG mice 2 and 28 days after 4HT administration
at P4. Error bars display mean + SEM.
(K and L) Confocal images showing EGFP and
MBP immunoreactivity in the cortex (CTX) (K)
and striatum (ST) (L) of PDGFaR-CreER;Z/EG
mice at P4+28. Yellow arrows indicate co-localiza-
tion between EGFP and MBP. Scale bars repre-
sent 20 mm.
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Fate of NG2+ Cells in Health and Diseasedifferentiated into immature or mature OLs. Together, these
results suggest that the majority of NG2+ cells in white and
gray matter of the developing brain rapidly mature into OLs
within a few weeks after birth.
NG2+ Cells Continue to Generate OLs in the Adult Brain
and Spinal Cord
Although OLs are generated rapidly during the first postnatal
month in mice, NG2+ cells remain abundant in both gray and
white matter in the adult CNS, many of which retain the ability
to proliferate. To determine if these resident NG2+ cells continue
to develop into OLs, we followed their fate in PDGFaR-CreER;Z/
EG mice over 4 months beginning at P30 or P70. At P30+4,
EGFP+ cells were observed throughout the forebrain; almost all
were PDGFaR+ (Figures 2A, 2B, and 2G; Figures S1B and
S1D), and EGFP was expressed by 40%–45% of all NG2+ cells.
Four months after 4HT administration (P30+120), EGFP+ cells
remained widely distributed (Figure 2C), but at this time point
90% of EGFP+ cells in the corpus callosum and 50% of
EGFP+ cells in the cortex were PDGFaR–CC1+ OLs (Figures 2D
and 2G). The efficiency of recombination and extent of differen-
tiation were comparable between male and female mice
because the number of EGFP+ cells at P30+4 (107 versus
102/mm2 in female and male mice, respectively) and the
percentage of CC1+ EGFP+ OLs in the corpus callosum at670 Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc.P30+120 (94% versus 88% in female
andmalemice, respectively) were similar;
therefore, data from both genders have
been pooled. EGFP+ cells that did not
express PDGFaR or CC1 were likely
immature or premyelinating OLs becausethey were Olig2+ and Sox10+, and had highly branched
processes characteristic of OL lineage cells at this stage of
development (Figure S1D, white arrowhead). The development
of OLs in the corpus callosum between P34 and P150 was
gradual because intermediate numbers of CC1+EGFP+ cells
were observed at P30+60 (Figure 2G). Although NG2+ cells in
both white and gray matter continued to generate OLs in adult
mice, the proliferation and differentiation of NG2+ cells were
higher in white matter; the number of EGFP+ cells in the corpus
callosum increased 4.6-fold in 4 months (p = 2.9 3 106),
whereas they did not increase significantly in the cortex over
this period (1.1-fold, p = 0.18) (Figure 2G). Moreover, the
percentage of CC1+EGFP+ cells was significantly higher in the
corpus callosum than in cortex at P30+120 (92% ± 2% versus
48% ± 3%, p < 1.0 3 107).
When Cre activity was induced in PDGFaR-CreER;Z/EGmice
at P70 and examined 5 or 60 days later, a similar increase in
CC1+ EGFP+ cells was observed (Figure 2H). Although there
were fewer EGFP+ cells at P70+5 compared to P30+4, presum-
ably reflecting less efficient Cre induction or recombination in
older mice, the percentage of EGFP+ cells that were PDGFaR
after 2 months was similar to that observed in the corpus cal-
losum at P30+60 (86% versus 79%, p = 0.19). These data
suggest that the rate at which NG2+ cells exit from progenitor
state in this brain area is stable for several months after the
Figure 2. NG2+ Cells Continue to Generate OLs in the Adult Mouse Brain and Spinal Cord
(A, C, and E) Images of EGFP+ cells and DAPI staining in coronal brain sections (A andC) and lumbar spinal cord (E) fromPDGFaR-CreER;Z/EGmice taken 4 (A) or
120 days (C and E) after 4HT administration at P30. Yellow boxes highlight regions expanded in (B), (D), and (F). Scale bars represent 500 mm.
(B, D, and F) Confocal images showing EGFP, PDGFaR, and CC1 immunoreactivity for the regions highlighted in (A), (C), and (E). Yellow arrows indicate
EGFP+PDGFaR+ cells, and white arrowheads indicate EGFP+CC1+ OLs. Scale bars represent 50 mm.
(G–J) Histograms showing the number of EGFP+ NG2+ cells (PDGFaR+), pre-myelinating OLs (PDGFaRCC1), and mature OLs (PDGFaRCC1+) in the cortex
(CTX) and corpus callosum (CC) of the brain (G and H), and in the gray (GM) and white matter (WM) of the spinal cord (I and J) in PDGFaR-CreER;Z/EGmice at
different times after 4HT administration at P30 (G and I) or P70 (H and J). Error bars display mean + SEM.
The number of EGFP+ cells increased significantly in the corpus callosum (p = 1.3 3 106, by one-way ANOVA) and spinal cord (p = 2.2 3 109 for GM, and
p = 0.011 for WM by one-way ANOVA) from 4 to 60 and 120 days after 4HT administration at P30. EGFP+ cell number also increased in the cortex, corpus cal-
losum, and spinal cord graymatter from 5 to 60 days after 4HT administration at P70. *p < 0.05; **p < 0.005; ***p < 1.03 104; n.s., not significant, when evaluated
by the Student’s t test.
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Fate of NG2+ Cells in Health and Diseasepeak of myelination. However, the maturation rate of these cells
slowed with age because fewer EGFP+ PDGFaR cells became
CC1+ over this 2 month period (83% versus 61%, p = 0.0054)
(Figures 2G and 2H). These results indicate that NG2+ cells
generate OLs continuously in both the dorsal cortex and corpus
callosum for at least 5 months after birth and that both the rate ofproliferation and the extent of differentiation of these progenitors
are greater in white matter in the adult brain.
NG2+ cells also generated OLs in the spinal cord during
postnatal development because EGFP+CC1+ cells increased in
both white and gray matter of the lumbar spinal cord with time
after 4HT administration (Figures 2E and 2F). The rates ofNeuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc. 671
Figure 3. NG2+ Cells in the Mature Brain Are Not Postmitotic or Terminally Differentiated
(A) Images of EGFP+ cells exhibiting PDGFaR, BrdU, and CC1 immunoreactivity in the cortex of PDGFaR-CreER;Z/EGmice after exposure to a low dose of 4HT.
Mice were examined at P30+4 (top), P30+30 (middle), and P30+80 (bottom). A single clone is highlighted by a dashed circle (middle). Yellow arrows highlight
EGFP+ PDGFaR+ cells (top) and EGFP+BrdU+ cells (middle), and white arrowheads highlight an EGFP+BrdU– CC1+ cell (middle) and EGFP+ PDGFaR cells
(bottom). Asterisks indicate an EGFP+BrdU+CC1+ OLs (middle). Scale bars represent 50 mm.
(B and C) Confocal images of EGFP+BrdU+ cell clusters representing individual clones located in the corpus callosum (B) or in hippocampus (C) from PDGFaR-
CreER;Z/EG mice at P30+30 or at P30+80, respectively. White arrowheads indicate either EGFP+CC1+ (B) or EGFP+PDGFaR (C) OLs. Scale bar represents
50 mm.
(D) Histograms showing the frequencyof EGFP+ cell clones of different sizes in the cortex (CTX) andcorpus callosum (CC) at P30+80 inPDGFaR-CreER;Z/EGmice.
(E)Histogramsshowing thepercentageofPDGFaROLs inEGFP+cell clonesofdifferentsizes in thecortex (CTX)andcorpuscallosum(CC) for theclonesshown in (D).
(F) Table showing the average size of EGFP+ cell clones in the dorso-lateral cortex (CTX), piriform cortex (Piri CTX), hippocampus (HP) and corpus callosum (CC),
the percentage of PDGFaR cells in each clone, the number of clones, and the number of clones that had at least one PDGFaR OL (EGFP+PDGFaR cell).
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Fate of NG2+ Cells in Health and DiseaseNG2+ cell proliferation were significantly slower in spinal than
subcortical (brain) white matter from P30, as EGFP+ cells in
spinal cord white matter increased by only 2.3-fold in 4 months.
In addition, only 25% of EGFP+ cells were CC1+ at P30+120,
suggesting that there also was a lower rate of NG2+ cell differen-
tiation in the spinal cord. Moreover, there was no significant
difference in the proportion of CC1+ EGFP+ cells between white
and gray matter in the spinal cord (p = 0.13). The reduced prolif-
eration and differentiation of NG2+ cells and the smaller disparity
between gray and white matter likely reflect the more advanced
stage of OL development and myelination in the spinal cord at
this age. Together, these results indicate that NG2+ cells that
reside in the adult brain and spinal cord continue to differentiate672 Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc.into OLs. Differences in the behavior of these progenitors
among CNS areas could arise from cell-extrinsic differences in
local environment. Alternatively, NG2+ cells may be heteroge-
neous with regard to their intrinsic capacity to proliferate and
differentiate.
NG2+ Cells in Gray Matter Are Not Postmitotic
and Retain the Ability to Generate OLs
Clonal analysis offers the opportunity to study the diverse behav-
iors of individual progenitors in different brain regions. When
PDGFaR-CreER;Z/EG mice were given a low dose of 4HT at
P30 and analyzed 4 days later, a small number of EGFP+
PDGFaR+ cells were visible throughout the brain (Figure 3A, top
Figure 4. OLs Generated from NG2+ Cells Form Myelin
Electron micrographs of the corpus callosum (A–C) and cortex (E–G) from
PDGFaR-CreER;ROSA26-mGFP mice at P30+150 showing silver-enhanced
immunogold labeling of EGFP. Arrows highlight silver particles located within
myelin sheaths, and arrowheads in (E) and (G) indicate myelin. Black boxes in
(A), (C), and (F) are shownathighermagnification in (B), (D), and (G), respectively.
MA, myelinated axon; OP, OL process; CC, corpus callosum; CTX, cerebral
cortex. Scale bars represent 100 nm (A, C, and F) or 500 nm (B, D, E, and G).
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Fate of NG2+ Cells in Health and Diseasepanels). Most were well isolated from other EGFP+ cells andwere
BrdU (85%) after continuous delivery of BrdU from P30 to P34;
the remainder consisted of closely apposed (within 10 mm) BrdU+
cell pairs. Whereas NG2+ cell somata were separated by 38 ±
2 mm at this age (n = 50), EGFP+ cell somata were separated by
230 ± 42 mm (n = 22), showing that this approach can achieve
sparse labeling of NG2+ cells. After 30 days (P30+30), isolated
clusters of EGFP+ cells were evident in the brains of these mice
(Figure 3A middle panel), which we assumed arose from clonal
expansion of individual NG2+ cells. Indeed, whenBrdUwas deliv-
ered continuously for up to 1 month, all EGFP+ cells within clus-
ters were BrdU+ (n = 45 clusters), suggesting that each cluster
arose through proliferation rather than long-distance migration
(Figure 3A middle and Figure 3B). Eighty days later (P30+80), all
isolated EGFP+ cells in the cortex and corpus callosum were
PDGFaR and Olig2+ (n = 11), indicating that they had differenti-
ated into pre-myelinating or mature OLs, whereas clusters of
EGFP+ cells in both gray and white matter contained both
PDGFaR+ and PDGFaR cells (Figures 3A–3C and 3F). These
findings suggest that NG2+ cells in all brain regions retain mitotic
activity until they differentiate into OLs. EGFP+ cell clusters in the
corpus callosum contained significantly more cells at P30+80
than in the cortex (corpus callosum: 5.3 ± 1 cells, n = 19; cortex:
3.6 ± 0.3, n = 52; p = 0.03) (Figures 3D and 3F), in accordancewith
the higher rate of NG2+ cell proliferation in white matter (Fig-
ure 2G). Moreover, nearly all (98%) EGFP+ cells within clusters
in the corpus callosum were PDGFaR (Figure 3E), whereas the
proportion of PDGFaR cells within clusters in gray matter varied
between brain regions (Figure 3F). Despite these regional differ-ences in the propensity of NG2+ cells to differentiate, 89% of
EGFP+ cell clusters in gray matter contained one or more
PDGFaR cells, suggesting that most, if not all, NG2+ cells in
the mature brain are capable of becoming OLs. Although
reporter-positive pericytes were occasionally observed in
PDGFaR-CreER;Z/EGmice (Figure S1H), they were not observed
in clones with NG2+ cells or OLs, indicating that these perivascu-
lar cells have a distinct lineage.
OLs Derived from NG2+ Cells in the Mature
Brain Form Myelin
The continuous appearance of CC1+ EGFP+ cells after P30 and
P70 suggests that NG2+ cells develop into mature OLs in the
adult CNS (Figure 2). However, it was not possible to determine
whether these cells extend processes to create myelin sheaths
because cytosolic EGFP is largely excluded from these thin
processes (Figures 2D and 5G). To aid in visualization of OL
processes, we used PDGFaR-CreER;ROSA26-mGFP (mT/mG)
mice, in which membrane-anchored EGFP is expressed
following Cre-mediated recombination (Muzumdar et al.,
2007). Two days after 4HT administration at P30, EGFP was
present in most PDGFaR+ cells in the corpus callosum (91%)
and cortex (94%) (Figures S3E and S4A and Table S1). Over
the next 4 months, there was a progressive increase in EGFP
fluorescence along myelinated tracts within the corpus callosum
(Figure S4A) and striatum at sites where myelin basic protein
(MBP) immunoreactivity was concentrated (Figure S4B). At
higher magnification, EGFP+ processes of OLs were co-local-
ized with MBP (Figures S4B–S4F). Although some EGFP+ cells
were observed without 4HT exposure (Figures S4A bottom
and Table S1), these OL lineage cells contributed little to the
overall patterns observed (Figure S4A).
To determine if NG2+ cell-derived OLs formmyelin sheaths, we
performed silver-enhanced immunogold labeling of EGFP on thin
sections prepared from P30+150 PDGFaR-CreER;ROSA26-
mGFPmice. In both corpus callosum and cortex, silver-enhanced
gold particles were observed within the membranous sheets of
myelin surrounding axons (Figures 4A–4D). These particles were
often most evident in the portions of the OL cytoplasm adjacent
to compacted myelin (Figures 4F and 4G). Together, these results
indicate that NG2+ cells generate myelinating OLs in both gray
and white matter of the adult brain.
NG2+ Cells Do Not Develop into Astrocytes
in the Postnatal Brain, Spinal Cord, or Optic Nerve
Recent studies have reported that NG2+ cells also generate
astrocytes in some areas of the postnatal brain and spinal cord
(Guo et al., 2009; Zhu et al., 2008a, 2008b). However, none of
the EGFP+ cells (0/4571 cells) in brain and spinal cord at these
different ages exhibited immunoreactivity to the astrocyte-
specific proteins GFAP or aldehyde dehydrogenase 1 family
member L1 (ALDH) (Figure 5A–5E). Because it can be chal-
lenging to unambiguously identify astrocytes using antibodies
against these proteins, we also used morphological criteria to
identify astrocytes. Administration of 4HT to P10 GLAST-
CreER;Z/EG or P15 GLAST-CreER;ROSA26-mGFP mice re-
sulted in EGFP expression in many GFAP+ or ALDH+ cells that
had highly ramified, complex morphologies typical of astrocytesNeuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc. 673
Figure 5. NG2+ Cells in the Postnatal Brain Do Not Generate Astrocytes
(A–E) Confocal images showing immunoreactivity to EGFP, ALDH, Olig2, and GFAP in the dorsal cortex (CTX; A and C), ventral forebrain (VB; B), hippocampus
(HP; D), and spinal cord (SC; E) in PDGFaR-CreER;Z/EG mice at P4+96 (A and B) or P30+120 (C–G).
(F–K) Comparison of the morphologies of EGFP+ cells from PDGFaR-CreER;Z/EG mice at P30+120 (F and G), GLAST-CreER;Z/EG at P11+10 (H), or GLAST-
CreER;ROSA26-mGFP mice at P15+21(I–K). Confocal images of EGFP+ cells from cortex (F–I), hippocampus (J), or ventral forebrain (K). Yellow asterisks high-
light mature OLs, in which cytosolic EGFP is visible only within the soma (G). Yellow arrows in (J) and (K) showEGFP+ astrocytes that were GFAP+ or ALDH+. Scale
bars represent 20 mm.
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were Olig2 (Figure 5I) and were readily distinguished from
Olig2+ OL lineage cells. Notably, EGFP+ cells with the
morphology of astrocytes were never observed in the brain or
spinal cord of PDGFaR-CreER;Z/EG mice (Figures 5F and 5G),
or in PDGFaR-CreER;ROSA26-EYFP mice at P30+120 (data
not shown), where at least 80% NG2+ cells were sampled (Table
S1). Although it was previously reported that perinatal OPCs (O-
2A progenitors) in the optic nerve can also becomeGFAP+ type 2
astrocytes (Ffrench-Constant and Raff, 1986), no EGFP+GFAP+
cells were observed in the optic nerve at various times after
4HT administration (0/477 cells) (Figure S5). Together, these
results suggest that NG2+ cells are not progenitors for astrocytes
in the postnatal CNS.
NG2+ Cells in the Postnatal Brain Do Not Develop
into Neurons
Recent studies also have reported that NG2+ cells serve as
progenitors for GABAergic interneurons (Aguirre and Gallo,
2004; Aguirre et al., 2004) and glutamatergic principal neurons
in vivo (Guo et al., 2009; Rivers et al., 2008). Although EGFP+
cells with neuronal morphologies were not observed in the
dorso-medial cortex and corpus callosum, EGFP+ cells with
large cell bodies and dendrite-like processes were occasionally
observed in other brain regions in PDGFaR-CreER;Z/EG mice,
particularly in ventral structures such as hypothalamus (Figures
S6A–S6D). These atypical EGFP+ cells were PDGFaR and
Olig2, but NeuN+ (Figures S6C and S7B), suggesting that
they were neurons. These cells were rare; fewer than four
EGFP+ neurons were found in each 35 mm thick coronal section,
which contained >2000 EGFP+ OL lineage cells. Labeling of674 Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc.these neurons was likely Cre dependent because they were
not observed in animals treated with vehicle alone. However,
EGFP+ neuronswere visible within several days after 4HT admin-
istration (at P30); if they developed from NG2+ cells, these
progenitors would have had to transform into neurons with
unprecedented speed because neurons derived from NSCs in
the hippocampus and lateral ventricle require 1.5–2 weeks to
exhibit NeuN immunoreactivity (Zhao et al., 2008). If NG2+ cells
serve as neuronal progenitors, the number of EGFP+ NeuN+
neurons also should increase with time after 4HT (Rivers et al.,
2008), assuming that the newly generated neurons survive.
However, greater numbers of EGFP+ neurons were not observed
with increasing time after 4HT (Figures S6E and S6F).
NG2+ cells have been reported to generate neurons in the den-
tate gyrus (Aguirre et al., 2004), olfactory bulb (Aguirre and Gallo,
2004), and piriform cortex (Guo et al., 2009; Rivers et al., 2008).
Although no EGFP+ neurons were observed in these regions in
PDGFaR-CreER;Z/EG mice (Figure S6D for piriform cortex), it
is possible that the subset of NG2+ cells with neurogenic poten-
tial were not sampled because only 25%–45% of NG2+ cells
became EGFP+ in these mice (Table S1). However, in
PDGFaR-CreER;ROSA26-mGFP mice, where more than 90%
of NG2+ cells were labeled (Table S1), EGFP+ NeuN+ neurons
also were not observed in the piriform cortex, dentate gyrus, or
olfactory bulb, either 4 days (P30+4) or 150 days (P30+150) after
4HT administration (Figures 6A–6I). All EGFP+ cells in these mice
at P30+150 were Olig2+ (Figure 6J–6L).
Neurogenesis in the subventricular and subgranular zones
occurs through asymmetric division of NSCs (Gould, 2007;
Zhao et al., 2008). Thus, if EGFP+ neurons in PDGFaR-CreER
mice are derived from NG2+ cells, it is expected that they would
Figure 6. NG2+ Cells Do Not Give Rise to
Neurons in the Postnatal CNS
(A–C) Images of EGFP+ cells in the piriform cortex
(Piri CTX; A), dentate gyrus (DG; B), and olfactory
bulb (OB; C) of PDGFaR-CreER;ROSA26-mGFP
mice at P30+150.
(D–F) Confocal images showing EGFP and NeuN
immunoreactivity in the regions highlighted by
the yellow boxes in (A)–(C). Orthogonal views are
shown in (G)–(I) to indicate the spatial relationship
between the NeuN+ neurons and EGFP+ cells indi-
cated by the white arrowheads.
(J–L) Confocal images of EGFP+ cells exhibiting
Olig2+ immunoreactivity in these brain regions.
Yellow arrows highlight several EGFP+Olig2+ cells.
Scale bars represent 100 mm (A–C), 50 mm (D–F),
and 20 mm (G–L).
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ability of detecting dividing neuronal progenitors,ROSA26-EYFP
reporter mice were used to maximize NG2+ cell sampling
(Figures S3A–S3D and Table S1), and NG2+ cells were pre-
labeled by continuously delivering BrdU to PDGFaR-CreER;
ROSA26-EYFP mice for 11 or 21 days beginning at P23 (Fig-
ure S7A). Although 83% of NG2+ cells in the hypothalamus
were BrdU+ at P30+14, none of the EYFP+NeuN+ cells observed
were BrdU+ (n = 53) (Figure S7B). Together, these results
suggest that NG2+ cells do not serve as progenitors for neurons
in the postnatal brain and that the infrequent appearance of
reporter-positive neurons arose from direct Cre expression in
these cells.Proliferating NG2+ Cells in ALS Spinal CordDifferentiate
into OLs, but Not Astrocytes or Neurons
NG2+ cells can develop into most major CNS cell types in vitro
when exposed to different growth factors (Kondo and Raff,
2000), suggesting that environmental cues can influence theNeuron 68, 668–681, Nfate of these progenitors. Although our
studies indicate that the fate of NG2+
cells was confined to the OL lineage in
the normal CNS, NG2+ cells may adopt
diverse fates following injury or during
disease, when cytokine and growth factor
levels change. It has been proposed that
NG2+ progenitors in the spinal cord may
have the ability to differentiate into astro-
cytes in ALS mice (Magnus et al., 2008),
astrocytes and microglia after contusion
injury (Sellers et al., 2009), and astrocytes
and Schwann cells following focal injec-
tion of the demyelinating agent lysoleci-
thin (Zawadzka et al., 2010). To determine
whether NG2+ cells exhibit lineage plas-
ticity in the context of a primary neurode-
generative disease, we followed the fate
of these progenitors in the spinal cord of
a mouse model of ALS (SOD1, G93A)(Gurney et al., 1994), in which progressive neurodegeneration
and gliosis occur in a highly reproducible manner without
external manipulation. Previous studies have shown that both
neurons (Gurney et al., 1994) and astrocytes (Rossi et al.,
2008) degenerate in the spinal cord of these mice, and astro-
cytes have been shown to incorporate BrdU (Guan et al., 2007;
Magnus et al., 2008), suggesting that some astrocytes are
replaced. Although the fate of OLs has not been determined in
this model, it is also possible that they degenerate following
the loss of motor neurons. Moreover, disease progression is
accompanied by microglial activation, inflammation (Papadimi-
triou et al., 2010), disruption of the blood-spinal cord barrier,
and a reduction in microcirculation (Zhong et al., 2008). Thus,
ALS mice provide the opportunity to study the behavior of
NG2+ cells in vivo in the context of extensive reactive changes
that accompany cellular degeneration.
To examine how NG2+ cells in the spinal cord respond to
changes in their local environment in ALS mice, BrdU was
administered to SOD1 (G93A) mice for 2 days prior to analysis
at P75 (presymptomatic), P90 (symptomatic), or P120 (endovember 18, 2010 ª2010 Elsevier Inc. 675
Figure 7. Enhanced Proliferation of NG2+
Cells in the Spinal Cord of ALS Mice
(A) Sections of lumbar spinal cord from wild-type
(WT) and SOD1 mutant (G93A) mice showing
BrdU+ cells at the presymptomatic (upper panels)
and end stages (lower panels). Scale bars repre-
sent 500 mm.
(B) Confocal images showing BrdU, Olig2, and
NG2 immunoreactivity in the lumbar spinal cord
gray matter from WT and SOD1 (G93A) mice at
end stage. Yellow arrows indicate BrdU+NG2+
cells, and the white arrowhead represents an
NG2-expressing macrophage/microglia-like cell
(Iba1+Olig2). Scale bars represent 20 mm.
(C) Plot of the number of BrdU+ Olig2+ cells in the
lumbar spinal cord of wild-type and SOD1 (G93A)
mice during disease progression (from P75 to end
stage). The number of BrdU+ Olig2+ cells was
significantly greater at P90 and end stage in
SOD1 (G93A) mice than in age-matched wild-
type littermates. *p < 0.05; **p < 0.0001. Statistical
comparisons were made by Student’s t test.
(D) Histograms showing the number of NG2+ cells
(NG2+Olig2+), microglial cells (Iba1+), astrocytes
(GFAP+), and other (undefined) cells that were
BrdU+ in the lumbar spinal cord of wild-type and
SOD1 (G93A) mice at different ages.
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(p = 0.02) in the lumbar spinal cord by the symptomatic
stage, and 20-fold by end stage (p = 3.0 3 106 versus control)
(Figure 7), indicating that NG2+ cells contribute to the extensive
gliosis observed in this model of ALS. To determine the fate of
NG2+ cells in the spinal cord of these mice, we crossed
PDGFaR-CreER;Z/EGmice to SOD1 (G93A) mice, administered
4HT at P60 and examined EGFP+ cells at end stage (P120).
Consistent with the increase in BrdU incorporation by NG2+
cells, there was a significant increase in EGFP+ cells at end stage
as compared to control (p < 1.03 104) (Figures 8A, 8B, and 8E).
Moreover, a greater proportion of these EGFP+ cells were
PDGFaR and CC1+ in SOD1 (G93A) mice, indicating that
NG2+ cell differentiation was also enhanced (Figures 8C–8E).
Notably, none of the EGFP+ cells in SOD1 (G93A) mice exhibited
immunoreactivity to GFAP+ (0/1020 cells), Iba1+ (0/661 cells), or
NeuN+ (0/1511 cells) (Figures 8F–8I), indicating that NG2+ cells in
the spinal cord remain restricted to the OL lineage, despite the
extensive neurodegeneration and gliosis that occur at later
stages of this disease.
DISCUSSION
NG2+ cells constitute an abundant, widely distributed population
of glial cells in themammalian CNS that retain the ability to divide
during adult life. Because they can develop into both glial cells
and neurons in vitro, NG2+ cells may serve as multipotent
progenitors in vivo with the capacity to promote extensive cell
replacement. The fate of NG2+ cells in the mouse brain has
recently been evaluated in vivo using Cre-lox fate mapping in676 Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc.transgenic mouse lines (Dimou et al., 2008; Guo et al., 2009;
Rivers et al., 2008; Zhu et al., 2008a). Although these studies
observed that NG2+ cells are capable of generating OLs, they
also reported that NG2+ cells can develop into astrocytes and
neurons. However, conclusions about the alternative fate of
NG2+ cells remain controversial because NG2+ cells in some
cases generated astrocytes, but not neurons (Zhu et al.,
2008a, 2008b), whereas in others they gave rise to neurons,
but not astrocytes (Rivers et al., 2008), or both astrocytes and
neurons (Guo et al., 2009). These contrasting results were attrib-
uted to differences in the developmental stages examined or to
incomplete sampling of the population, implying that NG2+ cells
are comprised of distinct groups with different lineage potential
(Guo et al., 2009; Rivers et al., 2008).
In this study, we developed a line of PDGFaR-CreERmice that
allows sampling of up to 90% of NG2+ cells in the CNS during
both early postnatal and adult life. Inducible labeling of these
progenitors during early postnatal development revealed that
NG2+ cells gave rise to myelinating OLs in both gray and white
matter, in accordance with previous studies performed in rat
using OL lineage markers (Levine et al., 1993), BrdU (Horner
et al., 2000), and retrovirus (Levison et al., 1999). Moreover,
NG2+ cells retained this capacity into adulthood, as shown
recently using a different line of PDGFaR-CreER mice (Rivers
et al., 2008). However, in contradiction to previous reports, our
studies indicate that NG2+ cells do not develop into astrocytes
or neurons during postnatal life, even in the context of gliosis
and extensive neurodegeneration in the spinal cord of ALS
mice. These findings suggest that NG2+ cells are not multipotent
progenitors retained to generate diverse cell types in normal or
Figure 8. Enhanced Differentiation of NG2+
Cells into OLs in ALS Mice
(A and B) Images of EGFP and choline acetyl
transferase (ChAT) immunoreactivity in sections
of lumbar spinal cord from aged-matched, litter-
mate PDGFaR-CreER;Z/EG (A) and PDGFaR-
CreER;Z/EG;SOD1(G93A) (B) mice at P30+179.
Scale bars represent 500 mm.
(C andD) Confocal images of EGFP, PDGFaR, and
CC1 immunoreactivity in the lumbar spinal cord of
PDGFaR-CreER;Z/EG (C) and PDGFaR-CreER;
Z/EG;SOD1(G93A) (D) mice at P60+60. Yellow
arrows andwhite arrowheads indicate EGFP+PDG-
FaR+ cells and EGFP+CC1+ cells, respectively.
Scale bars represent 20 mm.
(E) Histograms of the number of EGFP+NG2+ cells
(PDGFaR+), pre-myelinating OLs (PDGFaRCC1).
and OLs (PDGFaRCC1+) in the lumbar spinal cord
of PDGFaR-CreER;Z/EG (control) and PDGFaR-
CreER;Z/EG;SOD1(G93A) mice (SOD) that were
administered 4HT at P60 and examined at end
stage (P120). ***p < 5.5 3 105 for comparisons
of the number of EGFP+ cells between WT and
SOD1(G93A) PDGFaR-CreER;Z/EGmice.
(F–I) Images of EGFP+ cells in PDGFaR-CreER;Z/
EG;SOD1(G93A) mice at P60+60 (end stage)
showing that thesecellswerenotGFAP+ astrocytes
(F), Iba1+ microglia (G), or NeuN+ neurons (H and I).
(I) Higher magnification image of boxed area in (H)
showing that all of EGFP+ cells were Olig2+. Scale
bars represent 20 mm.
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allow new OLs to be generated throughout life.
Sources of Heterogeneity in NG2+ Cell Behavior
By labeling a cohort of NG2+ cells in different gray and white
matter regions, it was possible to compare their rates of prolifer-
ation and differentiation at different times during development
across many CNS regions. These studies show that the prolifer-
ation, differentiation, and eventual maturation of postnatal NG2+
cells peaked in the mouse brain during early postnatal life and
slowed thereafter. However, NG2+ cell behaviors were not
homogeneous. These developmental changes occurred more
rapidly in gray matter regions such as the cortex than in white
matter regions such as the corpus callosum, consistent with
previous observations (Dimou et al., 2008; Rivers et al., 2008).
In contrast this difference in NG2+ cell behavior between white
and gray matter was not apparent in spinal cord, where the over-
all rate of oligodendrogenesis is slower than in brain during the
same period (between P30 and P120) (Figure 2). Previous
studies have shown that manipulation of EGF or PDGFaR
signaling in NG2+ cells has dramatic effects on their proliferation
and differentiation in vivo (Aguirre and Gallo, 2007; Calver et al.,
1998), raising the possibility that these regional differences in
NG2+ cell behavior reflect differential availability of growth
factors. An alternative, but not mutually exclusive, possibility is
that NG2+ cells are comprised of physiologically distinct
subgroups destined for different fates (Dimou et al., 2008; Kara-
dottir et al., 2008; Rivers et al., 2008). Consistent with the latterhypothesis, more than half of the NG2+ cells in the adult brain
failed to incorporate BrdU when it was delivered continuously
for several weeks to months (Dimou et al., 2008; Psachoulia
et al., 2009; Rivers et al., 2008), and in the mature cortex most
did not differentiate into OLs, suggesting that there may be
a population of quiescent or postmitotic NG2+ cells (Dimou
et al., 2008; Rivers et al., 2008).
To determine whether NG2+ cells are intrinsically heteroge-
neous in their ability to proliferate and differentiate, we
performed a clonal analysis in vivo (Figure 3) by inducing Cre-
mediated recombination in isolated NG2+ cells. Analysis of
discrete EGFP+ cell clusters several months after administration
of 4HT at P30 revealed that clones in white matter hadmore cells
and contained a greater proportion of OLs than in gray matter, as
expected from the higher rates of proliferation and differentiation
of NG2+ cells in white matter; however, 96% of clones within the
cortex also contained OLs, indicating that NG2+ cells within gray
matter retained the ability to differentiate. If a significant propor-
tion of NG2+ cells in brain is postmitotic, many isolated
EGFP+NG2+ cells should have been visible at the end of the
sample period (P30+80). However, all EGFP+NG2+ cells at this
age occurred in multicellular clusters, whereas all isolated
EGFP+ cells were PDGFaR, indicating that they had undergone
differentiation (Figure 3). These results suggest that all NG2+
cells in the mature brain, regardless of region, have the ability
to divide and differentiate into OLs. These data do not support
the conclusion that there is a distinct subpopulation of NG2+
cells that is postmitotic (Dimou et al., 2008; Rivers et al., 2008)Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc. 677
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2008). The persistent differentiation of NG2+ cells into OLs in the
adult CNS raises the possibility that OLs in both the brain and
spinal cord periodically degenerate or that previously unmyelin-
ated axons become myelinated. The decline in proliferation of
NG2+ cells with age (Psachoulia et al., 2009; Rivers et al.,
2008), which occurs most prominently in gray matter areas,
may reflect local decreases in need for new OLs or limited
access to growth factors, rather than transition to a postmitotic
state.NG2+ Cells in the Postnatal CNS Do Not Develop
into Astrocytes
Despite extensive sampling of resident NG2+ cells, EGFP+ (or
EYFP+) astrocytes were not observed in either brain or spinal
cord, regardless of postnatal developmental stage or period of
fate tracing (Figure 5). These findings are in agreement with
observations made by Rivers et al. (2008), using a different line
of PDGFaR-CreER mice, but contrast with studies using other
lines of mice (Guo et al., 2009; Zhu et al., 2008a, 2008b). What
accounts for the discrepancy among studies that have examined
the fate of NG2+ progenitors? InNG2-Cremice (Zhu et al., 2008a,
2008b), Cre is constitutively expressed under control of the NG2
promoter. If this promoter is active in astrocytes or astrocyte
progenitors at any time during embryonic development, it would
result in the presence of reporter-positive astrocytes in the post-
natal CNS. Studies using PLP-CreER mice, in which Cre-medi-
ated reporter expression was induced within a subpopulation of
NG2+ cells, as well as mature OLs (Guo et al., 2009), also found
that astrocytes became reporter positive 8 days following 4HT
administration at P7. However, whereas more than 100 kb of
upstream and downstream regulatory sequence was used to
construct the PDGFaR-CreER BAC transgene, Cre expression
in PLP-CreER mice is controlled by a 2.4 kb fragment of the
PLP promoter (Doerflinger et al., 2003). It is possible that this
promoter sequence does not contain sufficient regulatory
elements to prevent Cre expression in cells outside the OL
lineage. We tested the specificity of promoter activity in the
same PLP-CreER;ROSA26-EYFP mice (Guo et al., 2009) and
observed many EYFP+ astrocytes and neurons less than 2 days
after 4HT administration to P7 mice (P7+1.5) (Figure S8). These
observations indicate that expression of Cre is not limited to OL
lineage cells in these mice, confounding clear interpretation of
these fate-tracing experiments.
Genetic fate-mapping studies also have been performed using
Olig2-CreER mice in which a CreER-encoding sequence was
placed within the Olig2 locus (Dimou et al., 2008). Although
Olig2 is a transcription factor that specifies OL fate (Ligon
et al., 2006), some reporter-positive astrocytes were visible in
Olig2-CreER mice when tamoxifen was administered to adult
mice (Dimou et al., 2008). However, as discussed by Dimou
et al. (2008), it is likely that Olig2 levels are significantly lower in
these heterozygous mice due to disruption of one Olig2 allele
by the CreER sequence (Takebayashi et al., 2002). Thus, it is
possible that reporter-positive astrocytes arise in these mice
because Olig2-dependent OL specification is weakened in
NG2+ cells or their progenitors (Zhou and Anderson, 2002).678 Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc.NG2+ Cells Do Not Develop into Neurons in the Postnatal
Brain
Among themost provocative questions concerning NG2+ cells is
whether they serve as progenitors for neurons in the postnatal
CNS. In support of this hypothesis, EGFP+ interneurons have
been observed in the dentate gyrus of CNP-EGFP mice (Be-
lachew et al., 2003), and some EGFP+NG2+ cells isolated from
the subventricular zone of perinatal CNP-EGFP mice developed
into interneurons after they were transplanted into neurogenic
regions of early postnatal brains (Aguirre andGallo, 2004; Aguirre
et al., 2004). In addition, reporter-positive projection neurons
were observed in recent Cre-lox fate-mapping studies using
both PLP-CreER mice (Guo et al., 2009) and a different line of
PDGFaR-CreER mice (Rivers et al., 2008). A small number of
EGFP+ neurons were present in our PDGFaR-CreER mice after
postnatal 4HT administration, particularly in ventral brain regions
(Figures S6 and S7). However, several observations suggest that
these reporter-positive neurons arose through direct expression
of CreER by neurons, rather than through differentiation of NG2+
cells. First, EGFP+ neurons were visible within a few days after
4HT exposure. By comparison, generation of morphologically
distinct NeuN+ neurons in the dentate gyrus requires several
weeks (Zhao et al., 2008), suggesting that it is unlikely that
NG2+ cells could undergo such a rapid morphological transfor-
mation, given that time is also required for translocation of Cre,
recombination, and EGFP expression. Second, in contrast to
Rivers et al. (2008), EGFP+ neurons did not accumulate over
time in our mice, as would be expected if NG2+ cells serve
continuously as neuronal progenitors. Third, although all
reported forms of neurogenesis in the CNS occur through asym-
metric division of progenitors (Gould, 2007; Zhao et al., 2008),
BrdU+ EGFP+ neurons were never observed, despite near satu-
ration of NG2+ cells with BrdU, as also reported by Rivers et al.
(2008). Thus, if these neurons developed from NG2+ cells, they
must have been formed through direct differentiation without
cell division. In this scenario, postmitotic NG2+ cells would be
expected but were not observed in our studies. Finally, we did
not observe any EGFP+ neurons in the pyriform cortex, dentate
gyrus, or olfactory bulb, regions where NG2+ cell-derived
neurons have been previously reported (Aguirre and Gallo,
2004; Aguirre et al., 2004; Guo et al., 2009; Rivers et al., 2008),
despite sampling of a larger proportion of the NG2+ cell popula-
tion (e.g., >90% of NG2+ cells in the piriform cortex). Thus, the
appearance of reporter-positive neurons in this study likely
resulted from direct expression of Cre by neurons, similar to
that reported by Dimou et al. (2008) inOlig2-CreERmice. Collec-
tively, our results suggest that NG2+ cells are not multipotent in
the normal brain and spinal cord.
NG2+ Cells Remain Lineage Restricted in the Spinal
Cord of ALS Mice
NG2+ cells in the adult CNS increase their rate of proliferation
and often undergo dramatic reactive changes in response to
acute injury or demyelination (Levine et al., 2001). Although our
studies indicate that NG2+ cells are constrained to the OL
lineage under normal conditions, alterations in growth factor
availability and exposure to cytokines in degenerating regions
could force greater lineage diversity. A demonstration of such
Neuron
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mature CNS are intrinsically multipotent and present new oppor-
tunities for initiating cell replacement through manipulation of
these endogenous progenitors. Moreover, because NG2+ cells
are widely distributed throughout the CNS, stimulation of these
progenitors could allow more extensive repair than is likely to
be achieved through cell transplantation or viral-mediated cell
transformation. Indeed, recent studies have reported that
NG2+ cells in the spinal cord develop into astrocytes, microglia,
and pericytes after spinal cord hemisection (Sellers et al., 2009),
and both astrocytes and Schwann cells after lysolecithin injec-
tion (Zawadzka et al., 2010).
In the SOD1(G93A) mousemodel of ALS, motor neurons in the
spinal cord degenerate, leading to progressive paralysis and
premature death (Gurney et al., 1994). This degeneration is
accompanied by extensive gliosis, involving proliferation, activa-
tion, and invasion of microglia/macrophages, as well as reactive
changes in astrocytes (Hall et al., 1998) and astrocyte degener-
ation (Rossi et al., 2008). Our studies, and those reported
previously (Magnus et al., 2008), indicate that NG2+ cells are
prominent contributors to this gliosis; by end stage they
were the most actively proliferating cells, with proliferation rates
20-fold higher than normal (Figure 7). Our fate-tracing results re-
vealed that a greater proportion of EGFP+ cells became CC1+ (or
PDGFaRCC1) by end stage, indicating that there is also
enhanced differentiation of these progenitors. However, no
EGFP+ neurons or astrocytes were observed, indicating that
NG2+ cells remained restricted to the OL lineage despite the
dramatic changes that occur in the spinal cord in this model of
ALS. Although the changes that occur in the spinal cord during
the course of disease in ALS mice, such as cell death, inflamma-
tion, and gliosis, also occur in neurodegenerative diseases such
as Alzheimer’s and Parkinson’s disease (Ilieva et al., 2009), and
following stroke and acute CNS trauma, it is possible that
NG2+ cells exhibit greater lineage plasticity in response to
different disease and injury conditions (Sellers et al., 2009; Za-
wadzka et al., 2010). Analysis of the behavior of NG2+ cells in
these different contexts may yield further insight into the factors
that regulate their behavior and the means to stimulate cell
replacement by manipulating the proliferation and fate of these
ubiquitous progenitors.
Why do NG2+ cells increase their rates of proliferation and
differentiation during the course of disease in ALS mice? If
NG2+ cells continue to serve as progenitors for OLs throughout
life, their behavior may be a response to degeneration of OLs
following motor neuron loss. It is possible that newly generated
OLs exist in a differentiated, but nonmyelinating state in these
mice, perhaps due to the lack of appropriate targets, and even-
tually undergo cell death. Such a continuous cycle of prolifera-
tion, differentiation, and death of OL lineage cells during the
course of this disease may consume resources and hasten the
demise of remaining neurons already under stress. Moreover,
because OLs are crucial for metabolic support of axons (Nave,
2010), a loss of OLs may further accelerate neuronal degenera-
tion. The ability to manipulate gene expression within NG2+ cells
in vivo using PDGFaR-CreER mice will help define the mecha-
nisms that underlie these changes in NG2+ cell behavior, as
well as the consequences of these changes for disease progres-sion in different neurodegenerative disorders and in response to
acute injury to the CNS.
EXPERIMENTAL PROCEDURES
Generation of PDGFaR-CreER Transgenic Mice
A BAC containing the mouse PDGFaR gene was modified by homologous
recombination method (Yang et al., 1997) to generate PDGFaR-CreER mice
(Supplemental Experimental Procedures). The PDGFaR-CreER mouse line
that exhibited the highest Cre recombination efficiency (line 467) was selected
for this study and maintained as hemizygous with various reporter mice. Z/EG,
ROSA26-EYFP, and ROSA26-mGFP (mT/mG) mice were purchased from the
Jackson Laboratory. All reporter mice were used as hemizygotes
or heterozygotes. GLAST-CreER BAC mice were kindly provided by
Drs. A. Rattner and J. Nathans (Johns Hopkins University, Baltimore, MD,
USA). SOD1 (G93A) mutant mice were obtained from the Jackson Laboratory
and crossed with PDGFaR-CreER;Z/EG mice. All experiments were carried
out in strict accordance with protocols approved by the Animal Care and
Use Committee at Johns Hopkins University.
Induction of Cre Activity and BrdU Administration
4-hydroxytamoxifen (4HT, Sigma H7904) was prepared as described previ-
ously (Badea et al., 2003), and 1mg or less was used per injection, unless
stated otherwise. Each mouse received up to two injections per day, at least
8 hr apart. A total of 0.1, 4, or 5 mg of 4HT was used for fate tracing from
P4, P30, or P70, respectively. A single dose of 0.5 mg was injected at P30
for clonal analysis. For continuous exposure to BrdU (Sigma), mice were
provided with BrdU-containing drinking water (1 mg/ml supplemented with
1% sucrose) and received daily injections of BrdU (BrdU in 0.9% NaCl,
50 mg /kg b.w., i.p.) additionally. For cell proliferation analysis in SOD1
(G93A) mice, BrdU (50 mg/kg) was injected twice per day, at least 8 hr apart,
for 2 days before analysis.
Immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbital (100 mg/kg b.w.)
and perfused transcardially with 4% paraformaldehyde (PFA in 0.1 M phos-
phate buffer [pH 7.4]). Brains and spinal cords were postfixed in 4% PFA over-
night at 4C, transferred to 30% sucrose solution (in PBS [pH 7.4]), and stored
at 4C for more than 36 hr. Tissue was sectioned (35 mm thick, unless stated
otherwise) with a cryostat, and immunofluorescence was performed on free-
floating sections. Brain (coronal, bregma 0.5 to 1.9 mm) and spinal cord
sections (from lumbar cord) were preincubated in blocking solution (5%
normal donkey serum, 0.3% Triton X-100 in PBS [pH 7.4]) for 1 or 2 hr at
room temperature, then incubated overnight at 4C in primary antibodies.
The primary and secondary antibodies used in this study are described in
Tables S2 and S3. For Olig2, ALDH, or APC(CC1) immunostaining, tissue
sections were incubated for 10 min in LAB solution (Polysciences) before
blocking. For BrdU immunostaining, sections were preincubated in 2 N HCl
at 37C for 30 min, followed by neutralization with 0.1 M sodium borate buffer
(pH 8.5) prior to immunolabeling. For combined immunostaining of BrdU and
EYFP, the EYFP signal was enhanced using the ABC kit (Vector Lab) and
TSA amplification system (Perkin Elmer) before acid denaturation. Secondary
antibody incubation was performed at room temperature for 2 hr. Sections
were mounted on slides with ProLong antifade reagent (Invitrogen). Confocal
images represent projected stacks of 15–45 images collected at 0.5–1.5 mm
steps.
Cell Counting and Analysis
Mounted slides were imaged using an epifluorescence microscope (Zeiss
Axio-imager M1) and Axiovision software (Zeiss), or a confocal laser-scanning
microscope (Zeiss LSM 510 Meta) using appropriate excitation and emission
filters. A total of 3–12 sections were examined per mouse, and 3–5 mice were
analyzed per group. For all studies except the clonal analysis, areas were
chosen randomly within the indicated regions of brain or spinal cord. Signifi-
cance was measured using the Student’s t test or one-way ANOVA, and all
data are reported as mean ± standard error of the mean (SEM).Neuron 68, 668–681, November 18, 2010 ª2010 Elsevier Inc. 679
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For pre-embedding immunoelectron microscopy, PDGFaR-CreER;mGFP
mice (P30+150) were perfused transcardially with 4% PFA/0.1% glutaralde-
hyde in 0.1 M PB under deep pentobarbital anesthesia. After blocking with
5% normal donkey serum in PBS, coronal sections (50 mm in thickness),
including the corpus callosum, were incubated overnight with rabbit anti-
EGFP IgG and then with anti-rabbit IgG conjugated to 1.4 nm gold particles
(Nanoprobes). Following silver enhancement (HQ silver, Nanoprobes),
sections were osmificated, dehydrated, and embedded in Epon 812 resin.
Ultrathin sections were prepared with an ultramicrotome (Leica Ultracut
UCT) and stained with 2% uranyl acetate. Electron micrographs were taken
with an H-7600 electron microscope (Hitachi, Tokyo, Japan).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and three tables and can be found with this article online at
doi:10.1016/j.neuron.2010.09.009.
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